Case records of the Massachusetts General Hospital. Case 19-2010. A 35-year-old man with adenocarcinoma of the cecum.
Ryan
David P
DP
Division of Hematology and Oncology, Massachusetts General Hospital, and Department of Medicine, Harvard Medical School, Boston, USA.
Engelman
Jeffrey A
JA
Ferrone
Cristina R
CR
Sahani
Dushyant V
DV
Lisovsky
Mikhail
M
D000230:Adenocarcinoma / Q000175:diagnosis* / Q000378:metabolism / Q000556:secondary / Q000628:therapy*; D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D000068258:Bevacizumab; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D002430:Cecal Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D000068818:Cetuximab; D003082:Colectomy; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D005472:Fluorouracil / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007150:Immunohistochemistry; D002955:Leucovorin / Q000008:administration & dosage / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000175:diagnosis / Q000556:secondary; D008297:Male; D009367:Neoplasm Staging; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D010166:Palliative Care; D010534:Peritoneal Neoplasms / Q000175:diagnosis / Q000556:secondary; D049268:Positron-Emission Tomography; D011379:Prognosis; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D016283:Proto-Oncogene Proteins p21(ras); D011553:Pseudomyxoma Peritonei / Q000175:diagnosis; D051598:Whole Body Imaging; D018631:ras Proteins / Q000378:metabolism
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C117307:KRAS protein, human; D009944:Organoplatinum Compounds; D047428:Protein Kinase Inhibitors; D011518:Proto-Oncogene Proteins; D000068258:Bevacizumab; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins; D000068818:Cetuximab; D002955:Leucovorin; D005472:Fluorouracil; D002166:Camptothecin